European biotech flourishes as US and Asian capital pours in
Despite benefiting from five times less investment compared with the US, the European biotech sector has blossomed in recent years, attracting increasing financing from a diversified mix of investors and producing several healthcare unicorns. Alessia Argentieri reports
More on Investments
M&A wave incoming in 2021, says Edmond de Rothschild CIO
Investment bank's H2 2020 outlook also emphasises continuing macroeconomic uncertainty, and singles out healthcare and data assets as winners
Buy-and-build: 3i’s five-step strategy
Pete Wilson, partner and head of UK private equity at 3i, outlines some key considerations for executing successful bolt-on acquisitions
Nordic e-commerce confident "silver krona" uplift will persevere
Lockdowns have – out of necessity – introduced a new age group to online shopping, boosting prospects for several PE-backed assets
Italian PE: an opportunity in crisis
The latest edition of Gatti Pavesi Bianchi's series on the Italian private equity and M&A markets is now available to download
Latest News
Triton's Eqos Energie bolts on AML Elektrotechnik
Austria-based electrical engineering company had filed for insolvency in April 2020
Aldea Ventures launches €150m fund-of-funds
VC house expects to hold a €35-45m first close by the end of July and a final close in around one year
17Capital provides £125m in preferred equity to Exponent III
LPs in Exponent III include Aberdeen Standard Investments, Central Pension Fund and CNP Assurances
NewAlpha acquires majority stake in CHR Numerique
Company has generated €12m in revenues and has a 25% EBITDA margin